Roland H Wagner1, Jörg Krenzien, Andreas Gussmann. 1. Department of Vascular and Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Teaching Hospital Humboldt University Berlin, Potsdam, Germany. rwagner@klinikumevb.de
Abstract
METHODS: 21 patients (17 men, 4 women; mean age 66.1 years, range 29-90 years) with 15 true aneurysms, and 6 type B-dissections were treated by implantation of a Talent Endoluminal Stentgraft System from February 2000 to July 2003. In 3 cases it was necessary to overstent the left subclavian artery, in 1 case to overstent the left common carotid. RESULTS: 2 patients (9.5%) died during the first 30 days (1 myocardial infarction, 1 pneumonia). Two patients (9.5%) suffered from cerebral ischemia and needed revascularisation. No paraplegia, no stroke occurred. One endoleak required additional stenting. No patient needed conversion. Follow-up, average 25.4 months (range 0-39), was 100% complete. During this another two patients died of myocardial infarction i.e. 9.5% (the above mentioned endoleak, but no late migration were detected in the remaining patients). In all cases the graft lumen stayed patent. CONCLUSIONS: Treatment of descending thoracic aortic aneurysm with an endovascular approach has acceptable mortality and morbidity-rates even in high risk patients. Procedural overstenting of the subclavian artery requires subclavian revascularisation in a minority of cases.
METHODS: 21 patients (17 men, 4 women; mean age 66.1 years, range 29-90 years) with 15 true aneurysms, and 6 type B-dissections were treated by implantation of a Talent Endoluminal Stentgraft System from February 2000 to July 2003. In 3 cases it was necessary to overstent the left subclavian artery, in 1 case to overstent the left common carotid. RESULTS: 2 patients (9.5%) died during the first 30 days (1 myocardial infarction, 1 pneumonia). Two patients (9.5%) suffered from cerebral ischemia and needed revascularisation. No paraplegia, no stroke occurred. One endoleak required additional stenting. No patient needed conversion. Follow-up, average 25.4 months (range 0-39), was 100% complete. During this another two patients died of myocardial infarction i.e. 9.5% (the above mentioned endoleak, but no late migration were detected in the remaining patients). In all cases the graft lumen stayed patent. CONCLUSIONS: Treatment of descending thoracic aortic aneurysm with an endovascular approach has acceptable mortality and morbidity-rates even in high risk patients. Procedural overstenting of the subclavian artery requires subclavian revascularisation in a minority of cases.
Authors: R Greenberg; T Resch; U Nyman; M Lindh; J Brunkwall; P Brunkwall; M Malina; B Koul; B Lindblad; K Ivancev Journal: J Vasc Surg Date: 2000-01 Impact factor: 4.268
Authors: T Temudom; M D'Ayala; M L Marin; L H Hollier; R Parsons; V Teodorescu; H Mitty; J Ahn; A Falk; R Kahn; R Griepp Journal: Ann Vasc Surg Date: 2000-05 Impact factor: 1.466
Authors: J Y Won; D Y Lee; W H Shim; B C Chang; S I Park; C S Yoon; H M Kwon; B H Park; G S Jung Journal: J Vasc Interv Radiol Date: 2001-05 Impact factor: 3.464
Authors: Robert Juszkat; Bartlomiej Perek; Bartosz Zabicki; Olga Trojnarska; Marek Jemielity; Ryszard Staniszewski; Wiesław Smoczyk; Fryderyk Pukacki Journal: PLoS One Date: 2013-12-26 Impact factor: 3.240